Rebamipide
- Generic Name
- Rebamipide
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C19H15ClN2O4
- CAS Number
- 90098-04-7
- Unique Ingredient Identifier
- LR583V32ZR
- Background
Rebamipide has been investigated for the treatment of Stomach Ulcer, Keratoconjunctivitis Sicca, and Gastric Adenoma and Early Gastric Cancer.
- Indication
主要用于胃溃疡，但不宜单独用于Hp感染。也用于改善胃炎及慢性胃炎急性加重期的胃黏膜病变（如糜烂、出血、充血、水肿等）。
- Associated Conditions
- Gastric Ulcer
- Associated Therapies
- -
Study of Rebamipide Eye Drops to Treat Dry Eye
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2006-11-02
- Target Recruit Count
- 740
- Registration Number
- NCT00201955
- Locations
- 🇺🇸
Vision Incorporated, Savannah, Georgia, United States
🇺🇸Philadelphia Eye Associates, Philadelphia, Pennsylvania, United States
🇺🇸Western Wake Eye Center, P.A., Cary, North Carolina, United States
Study of Rebamipide Eye Drops to Treat Dry Eye
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2008-01-07
- Target Recruit Count
- 740
- Registration Number
- NCT00201981
- Locations
- 🇺🇸
Montana Medical Research, LLC, Missoula, Montana, United States
🇺🇸Sall Eye Research Center, Artesia, California, United States
🇺🇸Western New York Eye Center, Orchard Park, New York, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath